DarioHealth announces 20-to-1 reverse stock split

DarioHealth (DRIO) announced that a reverse stock split of the company’s issued and outstanding common stock at a ratio of 20-for-1 is expected to be implemented at market open on August 28. The company’s common stock will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on August 28 under the company’s existing trading symbol “DRIO”, but will trade under a new CUSIP Number, 23725P 308.